1. Home
  2. CWBC vs OMER Comparison

CWBC vs OMER Comparison

Compare CWBC & OMER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CWBC
  • OMER
  • Stock Information
  • Founded
  • CWBC 1989
  • OMER 1994
  • Country
  • CWBC United States
  • OMER United States
  • Employees
  • CWBC N/A
  • OMER N/A
  • Industry
  • CWBC Major Banks
  • OMER Biotechnology: Pharmaceutical Preparations
  • Sector
  • CWBC Finance
  • OMER Health Care
  • Exchange
  • CWBC Nasdaq
  • OMER Nasdaq
  • Market Cap
  • CWBC 345.4M
  • OMER 397.1M
  • IPO Year
  • CWBC 1996
  • OMER 2009
  • Fundamental
  • Price
  • CWBC $18.17
  • OMER $3.21
  • Analyst Decision
  • CWBC Buy
  • OMER Strong Buy
  • Analyst Count
  • CWBC 3
  • OMER 5
  • Target Price
  • CWBC $20.67
  • OMER $18.00
  • AVG Volume (30 Days)
  • CWBC 54.4K
  • OMER 808.8K
  • Earning Date
  • CWBC 07-22-2025
  • OMER 08-06-2025
  • Dividend Yield
  • CWBC 2.64%
  • OMER N/A
  • EPS Growth
  • CWBC N/A
  • OMER N/A
  • EPS
  • CWBC 0.65
  • OMER N/A
  • Revenue
  • CWBC $120,399,000.00
  • OMER N/A
  • Revenue This Year
  • CWBC $34.50
  • OMER N/A
  • Revenue Next Year
  • CWBC $6.06
  • OMER $468.75
  • P/E Ratio
  • CWBC $27.92
  • OMER N/A
  • Revenue Growth
  • CWBC 38.79
  • OMER N/A
  • 52 Week Low
  • CWBC $15.57
  • OMER $2.97
  • 52 Week High
  • CWBC $22.89
  • OMER $13.60
  • Technical
  • Relative Strength Index (RSI)
  • CWBC 52.55
  • OMER 34.64
  • Support Level
  • CWBC $17.98
  • OMER $2.97
  • Resistance Level
  • CWBC $18.40
  • OMER $4.06
  • Average True Range (ATR)
  • CWBC 0.36
  • OMER 0.26
  • MACD
  • CWBC -0.02
  • OMER 0.10
  • Stochastic Oscillator
  • CWBC 50.41
  • OMER 22.02

About CWBC Community West Bancshares

Community West Bancshares is a bank holding company whose principal business is to serve as the holding company for its wholly-owned subsidiary Community West Bank N.A. Through CWB, the Company provides a variety of financial products and full-service Banking Centers within California's Greater Sacramento, San Joaquin Valley, and Central Coast regions, that provide Commercial Lending, Real Estate, Agribusiness, Private Banking, and Cash Management Departments.

About OMER Omeros Corporation

Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The drug candidate in the pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.

Share on Social Networks: